April 24, 2024
Biodegradable Scaffold Market

Biodegradable Scaffold Market in Trends toward Customization by Advancements in 3D Printing

The biodegradable scaffold market has become an essential part of tissue engineering and regenerative medicine. Biodegradable scaffolds act as a template for tissue formation and provide a structural support for cell attachment, growth, migration, and proliferation. Common biomaterials used in biodegradable scaffolds include collagen, gelatin, hyaluronic acid, chitosan, alginate, and PLGA. These scaffolds degrade gradually and get replaced by the host tissue. Key advantages of biodegradable scaffolds include promoting tissue regeneration without requiring removal by surgery.

The Global Biodegradable Scaffold Market is estimated to be valued at US$ 2.31 Bn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period from 2024 to 2031.

Advancements in 3D printing technologies are driving customization and personalization in biodegradable scaffolds. 3D printing enables the precise control over scaffold porosity, shape, and pore size to better mimic the extracellular matrix and facilitate tissue regeneration.

Key Takeaways

Key players: Key players operating in the Biodegradable Scaffold Market Size include Medtronic Plc, Koninklijke Philips N.V., Abbott, Johnson & Johnson Service Inc., Merit Medical Systems, Inc., Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Cerus Endovascular Limited., ASAHI INTECC USA, INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare, Veiva, and Nordson MEDICAL.

Growing demand: Rising incidences of chronic diseases and traumatic injuries have increased the demand for biodegradable scaffolds in tissue regeneration therapies. Biodegradable scaffolds help reduce postoperative complications and healing time.

Global expansion: Leading players are expanding their global footprint through partnerships, mergers, and acquisitions to meet the growing needs in both developed and emerging markets. In the coming years, Asia Pacific and Latin America are expected to offer high growth opportunities for biodegradable scaffold providers.

Market Key Trends

Customization through 3D printing is a major trend in the biodegradable scaffold market. 3D printing allows for precise control over scaffold design parameters based on patient-specific data. It enables the fabrication of complex porous scaffolds with high shape fidelity and reproducibility. 3D printed scaffolds can mimic the nanostructure of natural extracellular matrix more closely than traditional techniques. Going forward, advancements in 3D bioprinting with multiple cell and biomaterials will facilitate the manufacture of biomimetic scaffolds with potential for organ regeneration.

Porter’s Analysis
Threat of new entrants: The manufacturing process requires large capital investment and technical expertise, therefore threat is low.

Bargaining power of buyers: The market has many established players, so bargaining power of individual buyers is moderate.

Bargaining power of suppliers: Raw materials are easily available, so suppliers have low bargaining power.

Threat of new substitutes: New scaffold materials with better properties can emerge as substitutes, but threat is moderate due to regulations.

Competitive rivalry: Being a specialized market, rivalry among existing players over market share, brand, and innovation is high.

The biodegradable scaffold market in North America is currently the largest, valued at around US$ 1.23 billion in 2024. This is mainly attributed to the growing geriatric population, surgical procedures and product innovations in the region. The Asia Pacific region is projected to witness the fastest growth during the forecast period, mainly driven by rising healthcare expenditure, technological developments and expanding infrastructure in countries like China and India.

Geographical Regions
Europe accounts for the second largest share in the biodegradable scaffold market, valued at approximately US$ 560 million in 2024. This is due to the growing aging population, rising chronic diseases, and developing healthcare infrastructure in countries like Germany, UK and France. Latin America and Middle East & Africa currently hold a small combined share but are expected to offer lucrative growth opportunities during the forecast period.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it